Galván José A, García-Martínez Jorge, Vázquez-Villa Fernando, García-Ocaña Marcos, García-Pravia Carmen, Menéndez-Rodríguez Primitiva, González-del Rey Carmen, Barneo-Serra Luis, de los Toyos Juan R
Oncology University Institute of the Principality of Asturias (IUOPA), 33006 Oviedo, Spain.
BMC Cancer. 2014 Nov 23;14:867. doi: 10.1186/1471-2407-14-867.
The human COL11A1 gene has been shown to be up-regulated in stromal cells of colorectal tumours, but, so far, the immunodetection of procollagen 11A1, the primary protein product of COL11A1, has not been studied in detail in human colon adenocarcinomas. Some cancer-associated stromal cells seem to be derived from bone marrow mesenchymal cells; the expression of the COL11A1 gene and the parallel immunodetection of procollagen 11A1 have not been evaluated in these latter cells, either.
We used quantitative RT-PCR and/or immunocytochemistry to study the expression of DES/desmin, VIM/vimentin, ACTA2/αSMA (alpha smooth muscle actin) and COL11A1/procollagen 11A1 in HCT 116 human colorectal adenocarcinoma cells, in immortalised human bone marrow mesenchymal cells and in human colon adenocarcinoma-derived cultured stromal cells. The immunodetection of procollagen 11A1 was performed with the new recently described DMTX1/1E8.33 mouse monoclonal antibody. Human colon adenocarcinomas and non-malignant colon tissues were evaluated by immunohistochemistry as well. Statistical associations were sought between anti-procollagen 11A1 immunoscoring and patient clinicopathological features.
Procollagen 11A1 was immunodetected in human bone marrow mesenchymal cells and in human colon adenocarcinoma-associated spindle-shaped stromal cells but not in colon epithelial or stromal cells of the normal colon. This immunodetection paralleled, in both kinds of cells, that of the other mesenchymal-related biomarkers studied: vimentin and alpha smooth muscle actin, but not desmin. Thus, procollagen 11A1(+) adenocarcinoma-associated stromal cells are similar to "activated myofibroblasts". In the series of human colon adenocarcinomas here studied, a high procollagen 11A1 expression was associated with nodal involvement (p = 0.05), the development of distant metastases (p = 0.017), and advanced Dukes stages (p = 0.047).
The immunodetection of procollagen 11A1 in cancer-associated stromal cells could be a useful biomarker for human colon adenocarcinoma characterisation.
人类COL11A1基因已被证明在结直肠肿瘤的基质细胞中上调,但到目前为止,尚未在人类结肠腺癌中对COL11A1的主要蛋白质产物原胶原11A1进行详细的免疫检测研究。一些癌症相关的基质细胞似乎来源于骨髓间充质细胞;COL11A1基因的表达以及原胶原11A1的平行免疫检测在这些细胞中也未得到评估。
我们使用定量逆转录聚合酶链反应(RT-PCR)和/或免疫细胞化学来研究波形蛋白(VIM/vimentin)、结蛋白(DES/desmin)、α平滑肌肌动蛋白(ACTA2/αSMA)和原胶原11A1在HCT 116人结肠腺癌细胞、永生化人骨髓间充质细胞以及人结肠腺癌来源的培养基质细胞中的表达。原胶原11A1的免疫检测使用最近描述的新型DMTX1/1E8.33小鼠单克隆抗体进行。还通过免疫组织化学对人结肠腺癌和非恶性结肠组织进行了评估。研究了原胶原11A1免疫评分与患者临床病理特征之间的统计学关联。
在人骨髓间充质细胞和人结肠腺癌相关的梭形基质细胞中检测到原胶原11A1的免疫反应,但在正常结肠的结肠上皮或基质细胞中未检测到。在这两种细胞中,这种免疫检测与所研究的其他间充质相关生物标志物(波形蛋白和α平滑肌肌动蛋白)的免疫检测平行,但与结蛋白不同。因此,原胶原11A1阳性的腺癌相关基质细胞类似于“活化的肌成纤维细胞”。在本研究的人结肠腺癌系列中,原胶原11A1的高表达与淋巴结受累(p = 0.05)、远处转移的发生(p = 0.017)以及晚期杜克分期(p = 0.047)相关。
在癌症相关基质细胞中对原胶原11A1进行免疫检测可能是一种用于人类结肠腺癌特征化的有用生物标志物。